Bladder Urothelial Carcinoma

general

A carcinoma that arises from the urothelial lining of the bladder. It is the most common morphologic type of urinary bladder carcinoma. It usually affects males in their sixth and seventh decades of life. Hematuria is the most common symptom at presentation. Pathologic stage is the strongest predictor of survival.

80

Centers

241

Active Trials

$3.8B

Cancer Funding

Specific Cancer Types(6)

Top Centers for Bladder Urothelial Carcinoma(80)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.1
2
NCI Comprehensive
Active Research Program
66.5
3
NCI Comprehensive
Active Research Program
66.5
4
NCI Comprehensive
Active Research Program
66.5
5
NCI Comprehensive
Active Research Program
66.5
6
NCI Comprehensive
Active Research Program
66.5
7
NCI Comprehensive
Active Research Program
66.5
8
NCI Comprehensive
Active Research Program
66.5
9
Active Research Program
66.5
10
NCI Clinical
Active Research Program
66.5
11
NCI Comprehensive
Active Research Program
66.5
12
Active Research Program
66.5
13
Active Research Program
66.5
14
Active Research Program
66.5
15
Active Research Program
66.5
16
Active Research Program
66.5
1764.5
18
NCI Comprehensive
Active Research Program
63.9
19
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
63.4
20
NCI Comprehensive
Active Research Program
46.4
21
NCI Comprehensive
Active Research Program
46.4
22
NCI Comprehensive
Active Research Program
46.4
23
NCI Comprehensive
Active Research Program
46.4
24
NCI Comprehensive
Active Research Program
46.4
25
NCI Comprehensive
Active Research Program
46.4
26
NCI Comprehensive
Active Research Program
46.4
27
NCI Comprehensive
Active Research Program
46.4
28
NCI Comprehensive
Active Research Program
46.4
29
NCI Comprehensive
Active Research Program
46.4
30
NCI Comprehensive
Active Research Program
46.4
31
NCI Comprehensive
Active Research Program
46.4
32
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
46.4
33
NCI Comprehensive
Active Research Program
46.4
34
NCI Comprehensive
Active Research Program
46.4
35
NCI Clinical
Active Research Program
46.4
36
NCI Comprehensive
Active Research Program
46.4
37
NCI Comprehensive
Active Research Program
46.4
38
NCI Clinical
Active Research Program
46.4
39
NCI Comprehensive
Active Research Program
46.4
40
Active Research Program
46.4
41
NCI Comprehensive
Active Research Program
46.4
42
NCI Comprehensive
Active Research Program
46.4
43
NCI Comprehensive
Active Research Program
46.4
44
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
46.4
45
NCI Clinical
Active Research Program
46.4
46
NCI Comprehensive
Active Research Program
46.4
47
Active Research Program
46.4
48
NCI Comprehensive
Active Research Program
46.4
49
Active Research Program
46.4
50
Active Research Program
46.4
51
Active Research Program
46.4
52
Active Research Program
46.4
53
Active Research Program
46.4
54
Active Research Program
46.4
55
Active Research Program
46.4
56
Active Research Program
46.4
57
Active Research Program
46.4
58
Active Research Program
46.4
5929.6
60
NCI Comprehensive
29.6
61
NCI Comprehensive
29.6
62
NCI Comprehensive
29.6
63
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
29.6
6429.6
65
NCI Comprehensive
66
NCI Comprehensive
67
68
69
NCI Comprehensive
70
NCI Comprehensive
71
NCI Comprehensive
72
73
74
NCI Comprehensive
75
76
77
78
NCI Basic_laboratory
79
80

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →